AstraZeneca Pharma India Ltd. on announced the appointment of Dr. Sanjeev Panchal as Country President, effective 1 January 2023. Sanjeev has been with AstraZeneca for 19 years and began his career in India back in 2003 as a Brand Associate. Over time, he progressed through several positions in India, Indonesia, Asia Pacific and International region, based in Singapore and the UK.

He played a critical role in supporting the government in combating the pandemic through AstraZeneca's Covid-19 vaccine and long-acting monoclonal antibodies, as well as leading the Corporate Affairs strategy and sustainability initiatives, the company stated. Sanjeev is a Science graduate (BSc) with Post Graduation and Doctorate in Business Administration (PhD). Meanwhile, Gagandeep Singh has resigned from the post of Country President and Managing Director.

Sanjeev will be assuming the new role starting January 2023 and will be taking forward the commitment of the organisation in the country.